Friday , June 23 2017
Breaking News
Home / Business / Claris Lifesciences undergoes USFDA audit for Pharmacovigilance

Claris Lifesciences undergoes USFDA audit for Pharmacovigilance

Claris Lifesciences (CLL) along with its wholly owned subsidiary Claris Injectables (CIL) has underwent a successful USFDA Pharmacovigilance (PV) audit from May 29 to May 31 with No Observation (i483s).

Claris Lifesciences is engaged in manufacturing of drugs and pharmaceutical products. The Company manufactures and markets products across multiple delivery systems, markets and therapeutic segments, including anesthesia and analgesics, blood products, anti-invective’s, critical care, and nephrology.

About editor

Leave a Reply

Your email address will not be published. Required fields are marked *

*